Knee Arthroplasty, Total Clinical Trial
Official title:
The Effect of Local Anesthetic Volume Within the Adductor Canal on Quadriceps Function Evaluated by Electromyography: A Randomized, Observer-Masked, Placebo-Controlled Study in Volunteers.
Our aim is to investigate which components of the quadriceps femoris muscle are affected following an ACB with different volumes (10, 20 and 30 ml) of 1% lignocaine evaluated by electromyography. Both a placebo treatment (20ml saline) and the femoral nerve block (20ml lignocaine 1%) as an active comparative will be used for model control. Further, we want to investigate the effect of volume on motor block. This will be evaluated by measuring the Maximum Voluntary Isometric Contraction (MVIC) of the quadriceps femoris muscle.
Status | Completed |
Enrollment | 20 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age > 18 years old - Subjects who gave their written informed consent to participating in the study after having fully understood the contents of the protocol and re-strictions. - ASA 1 - Male - BMI 18-30 - Physical exercise 1-3 hours/week Exclusion Criteria: - Subjects who cannot cooperate with the study. - Subjects who cannot understand or speak Danish. - Subjects with allergy to the medicines used in the study. - Subjects suffering from alcohol and/or drug abuse - based on the investi-gator's opinion. - Pathology or previous surgery or trauma to the lower limb. - Intense exercise 24 h before the tests - Intake of any analgesics 24 h prior to baseline measurements. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Ulrik Grevstad |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference between ACB-groups, one hour post-block, in amplitude of the rectified vEMG signal from the vastus medialis, expressed as percentage of the pre-block value. | vEMG=voluntary electromyography | one hour post-block | No |
Secondary | • Difference between ACB-groups, one hour post-block, in amplitude of the rectified vEMG signal from the vastus lateralis, expressed as percentage of the pre-block value. | vEMG=voluntary electromyography | one hour post block | No |
Secondary | • Difference between groups, one hour post-block, in MVIC expressed as percentage of the pre-block value | MVIC=maximum voluntary isometric contraction. (Quadriceps femoris muscle) | one hour post-block | No |
Secondary | • Difference between ACB-groups, one hour post-block, in amplitude of the rectified sEMG signal from the vastus medialis, expressed as percentage of the pre-block value. | sEMG= stimulated Electromyography | one hour post-block | No |
Secondary | • Difference between ACB-groups, one hour post-block, in amplitude of the rectified sEMG signal from the vastus lateralis, expressed as percentage of the pre-block value. | sEMG= stimulated Electromyography | one hour post-block | No |
Secondary | • Association between volume and MVIC. MVIC expressed as a percentage of the pre-block value. | one hour post-block | No | |
Secondary | Difference in proportions between ACB-groups having an affection of both the saphenous nerve and the vastus medialis (but no other components of the quadriceps femoris muscle), one hour post block evaluated by EMG | For each subject a series of 5 voluntary EMG recordings during MVIC will be made to estab-lish the variability of the EMG recordings. This will be done prior to the blocks on each day resulting in 300 EMG recordings from the vastus medialis and 300 recordings from the vastus lateralis. From this variability we will establish a cut-off point (how large a decline in EMG amplitude is "synonymous" with affection of the nerve?). After the cut-off point has been established the EMG data will be presented in dichotomous form: affected/not affected | one hour post-block | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04226339 -
Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment
|
N/A | |
Completed |
NCT03276143 -
FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty
|
Phase 2 | |
Completed |
NCT03308071 -
Hypnosis for Symptom Management in Elective Orthopedic Surgery
|
N/A | |
Recruiting |
NCT05100706 -
Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty
|
N/A | |
Completed |
NCT04090125 -
Improving Physical Activity and Gait Symmetry After Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT04564729 -
Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing
|
N/A | |
Recruiting |
NCT03695640 -
Effect of Magnesium Sulphate on Analgesia Following Knee Arthroplasty
|
Phase 4 | |
Recruiting |
NCT05877261 -
Cementless Triathlon 5YR Follow-Up
|
||
Recruiting |
NCT05516381 -
Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic Alignment
|
N/A | |
Completed |
NCT04450485 -
Surgical Approach in Fast Track Knee Arthroplasty
|
N/A | |
Recruiting |
NCT06108063 -
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
|
Phase 1/Phase 2 | |
Recruiting |
NCT06389435 -
RObotic-assisted Versus Conventional Knee Endoprosthetic Techniques
|
N/A | |
Completed |
NCT03898544 -
Gait Kinematics After Primary Total Knee Arthroplasty (TKA) Versus Revision TKA
|
||
Completed |
NCT03492320 -
Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
|
||
Active, not recruiting |
NCT02445443 -
LEGION Hinge Safety and Efficacy Study
|
||
Terminated |
NCT02830087 -
Tourniquet Pressure in Primary Total Knee Arthroplasty
|
N/A | |
Completed |
NCT02186587 -
iTotal Pilot Study of ConforMIS Custom Total Knee Implant
|
N/A | |
Completed |
NCT00711711 -
Manual Lymphatic Drainage Following Total Knee Arthroplasty Surgery
|
N/A | |
Active, not recruiting |
NCT05788757 -
Optetrak Knee System Post Market Clinical Follow-Up
|
||
Completed |
NCT03703206 -
The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)
|
Phase 3 |